Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-(211)At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing

Targeted α-particle therapy is a promising option for patients with malignant pheochromocytoma. Recent observations regarding meta-(211)At-astato-benzylguanidine ((211)At-MABG) in a pheochromocytoma mouse model showed a strong anti-tumor effect, though the molecular mechanism remains elusive. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohshima, Yasuhiro, Kono, Nobuaki, Yokota, Yuichiro, Watanabe, Shigeki, Sasaki, Ichiro, Ishioka, Noriko S., Sakashita, Tetsuya, Arakawa, Kazuharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485192/
https://www.ncbi.nlm.nih.gov/pubmed/31037122
http://dx.doi.org/10.7150/thno.30353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485192/
https://www.ncbi.nlm.nih.gov/pubmed/31037122
http://dx.doi.org/10.7150/thno.30353

Ejemplares similares